Clinical Trial

The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 23, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus. The study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-05.
Trial Details
NCT Number NCT07334002
Lead Sponsor Sisli Hamidiye Etfal Training and Research Hospital
Conditions Tinnitus, Neural Therapy of Huneke
Enrollment 30 participants
Start Date 2026-03-01
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-26 (estimated)
Updated on ClinicalTrials.gov 2026-03-23